UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000015105 |
|---|---|
| Receipt number | R000017582 |
| Scientific Title | A randomized phase 2 trial which investigate the most effective administration method of antithrombin (AT) products in patients with disseminated intravascular coagulation (DIC) associated with sepsis during treatment for advanced pancreatic and biliary cancer. |
| Date of disclosure of the study information | 2014/09/10 |
| Last modified on | 2019/04/08 12:59:59 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/09/10 11:58:57 | ||
| 2 | Update | 2014/09/10 16:31:31 | Public title Acronym Acronym |
|
| 3 | Update | 2014/09/10 16:35:09 | Condition Narrative objectives1 Primary outcomes Key secondary outcomes |
|
| 4 | Update | 2014/09/10 16:42:14 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Key inclusion criteria Key exclusion criteria |
|
| 5 | Update | 2014/09/10 16:43:24 | Recruitment status |
|
| 6 | Update | 2017/05/16 19:19:46 | Randomization unit |
|
| 7 | Update | 2017/05/16 19:20:07 | Name of primary person or sponsor Organization |
|
| 8 | Update | 2019/04/08 12:59:59 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
